Michael Groeneweg

1.9k total citations
39 papers, 1.3k citations indexed

About

Michael Groeneweg is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, Michael Groeneweg has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Gastroenterology, 13 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Michael Groeneweg's work include Gastrointestinal motility and disorders (9 papers), Liver Disease and Transplantation (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Michael Groeneweg is often cited by papers focused on Gastrointestinal motility and disorders (9 papers), Liver Disease and Transplantation (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Michael Groeneweg collaborates with scholars based in Netherlands, Finland and United States. Michael Groeneweg's co-authors include Solko W. Schalm, Wim C.J. Hop, Juan C. Quero, Ieneke J. C. Hartmann, Marie‐Louise Essink‐Bot, Paul F. M. Krabbe, Robert A. de Man, Marc A. Benninga, Fleur de Lorijn and Marloes E.J. Bongers and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Michael Groeneweg

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Groeneweg Netherlands	15	808	783	520	203	155	39	1.3k
Einar S. Björnsson Sweden	23	303 0.4×	607 0.8×	799 1.5×	1.3k 6.6×	125 0.8×	29	2.2k
Jeremy Tibble United Kingdom	13	76 0.1×	683 0.9×	614 1.2×	253 1.2×	62 0.4×	35	1.6k
Joris Arts Belgium	26	170 0.2×	687 0.9×	1.7k 3.3×	1.7k 8.4×	50 0.3×	79	3.0k
Chin‐Lin Perng Taiwan	25	134 0.2×	228 0.3×	1.2k 2.3×	1.1k 5.6×	52 0.3×	71	1.9k
Pascal Perney France	20	612 0.8×	706 0.9×	199 0.4×	9 0.0×	111 0.7×	80	1.4k
Guillermo García‐Ramos Mexico	19	249 0.3×	258 0.3×	245 0.5×	19 0.1×	217 1.4×	64	1.2k
Sjoerd D. Kuiken Netherlands	17	115 0.1×	169 0.2×	565 1.1×	616 3.0×	21 0.1×	26	1.1k
Rajiv R. Varma United States	12	835 1.0×	794 1.0×	530 1.0×	29 0.1×	108 0.7×	27	1.2k
Christian Denzer Germany	19	53 0.1×	302 0.4×	212 0.4×	18 0.1×	43 0.3×	54	1.3k
József Czimmer Hungary	18	33 0.0×	109 0.1×	339 0.7×	253 1.2×	31 0.2×	42	797

Countries citing papers authored by Michael Groeneweg

Since Specialization

Citations

This map shows the geographic impact of Michael Groeneweg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Groeneweg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Groeneweg more than expected).

Fields of papers citing papers by Michael Groeneweg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Groeneweg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Groeneweg. The network helps show where Michael Groeneweg may publish in the future.

Co-authorship network of co-authors of Michael Groeneweg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Groeneweg. A scholar is included among the top collaborators of Michael Groeneweg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Groeneweg. Michael Groeneweg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeevenhooven, Judith, Johannes C. Kelder, Michael Groeneweg, et al.. (2025). Mebeverine and the Influence of Labeling in Adolescents With Irritable Bowel Syndrome or Functional Abdominal Pain Not Otherwise Specified: A 2 × 2 Randomized, Placebo-Controlled Trial. Gastroenterology. 169(1). 94–103. 1 indexed citations

Meij, Tim G. J. de, Obbe F. Norbruis, Michael Groeneweg, et al.. (2024). Randomised clinical trial: First‐line infliximab biosimilar is cost‐effective compared to conventional treatment in paediatric Crohn's disease. Alimentary Pharmacology & Therapeutics. 59(12). 1510–1520. 2 indexed citations

Cozijnsen, Martinus A., Tim de Meij, Obbe F. Norbruis, et al.. (2023). P448 Long term effectiveness of first-line infliximab treatment compared to conventional treatment in paediatric moderate-to-severe Crohn’s disease – an update from the TISKids study. Journal of Crohn s and Colitis. 17(Supplement_1). i579–i580. 1 indexed citations

Cozijnsen, Martinus A., Obbe F. Norbruis, Michael Groeneweg, et al.. (2022). Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease. European Journal of Pediatrics. 181(8). 3055–3065. 6 indexed citations

Browne, Pamela D., Herbert M. van Wering, Margreet Wessels, et al.. (2021). Skills or Pills: Randomized Trial Comparing Hypnotherapy to Medical Treatment in Children With Functional Nausea. Clinical Gastroenterology and Hepatology. 20(8). 1847–1856.e6. 11 indexed citations

Zeevenhooven, Judith, et al.. (2020). Clinical Evaluation of Inflammatory and Blood Parameters in the Workup of Pediatric Chronic Abdominal Pain. The Journal of Pediatrics. 219. 76–82.e3. 5 indexed citations

Stapersma, Luuk, Gertrude van den Brink, Jan van der Ende, et al.. (2019). Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up. Journal of Clinical Psychology in Medical Settings. 27(3). 490–506. 16 indexed citations

Browne, Pamela D., Herbert M. van Wering, Elvira K. George, et al.. (2019). Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial. BMJ Open. 9(4). e024903–e024903. 5 indexed citations

Costes, L M M, Dicky J. Lindenbergh-Kortleve, L A van Berkel, et al.. (2018). IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine. Mucosal Immunology. 12(2). 479–490. 25 indexed citations

10.

Rutten, Juliette M.T.M., Arine M. Vlieger, Elvira K. George, et al.. (2014). Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatrics. 14(1). 140–140. 39 indexed citations

11.

Hol, Jeroen, Y. Simons‐Oosterhuis, H.C. Raatgeep, et al.. (2014). Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor. Gut. 64(6). 884–893. 22 indexed citations

12.

Lindenbergh-Kortleve, Dicky J., H.C. Raatgeep, Lilian F. de Ruiter, et al.. (2013). Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease. Mucosal Immunology. 6(6). 1202–1213. 39 indexed citations

13.

Hop, Wim C.J., et al.. (2010). Plasma water as a diagnostic tool in the assessment of dehydration in children with acute gastroenteritis. European Journal of Pediatrics. 169(7). 883–886. 3 indexed citations

14.

Bongers, Marloes E.J., Fleur de Lorijn, Johannes B. Reitsma, et al.. (2007). The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial. Nutrition Journal. 6(1). 8–8. 80 indexed citations

15.

Bongers, Marloes E.J., Fleur de Lorijn, Johannes B. Reitsma, et al.. (2006). THE CLINICAL EFFECT OF A NEW INFANT FORMULA IN TERM INFANTS WITH CONSTIPATION: A DOUBLE‐BLIND, RANDOMIZED, CROSS‐OVER TRIAL. Journal of Pediatric Gastroenterology and Nutrition. 42(5).

16.

Borg, Pieter C. J. ter, Henk R. van Buuren, Frank P. Vleggaar, et al.. (2004). Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3–9 Years. Radiology. 231(2). 537–545. 45 indexed citations

17.

Groeneweg, Michael, et al.. (2000). Screening of subclinical hepatic encephalopathy. Journal of Hepatology. 32(5). 748–753. 159 indexed citations

18.

Groeneweg, Michael, Juan C. Quero, Ieneke J. C. Hartmann, et al.. (1998). Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 28(1). 45–49. 391 indexed citations

19.

Groeneweg, Michael, K. Gyr, R. Amrein, et al.. (1996). Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial. Electroencephalography and Clinical Neurophysiology. 98(1). 29–34. 19 indexed citations

20.

Gyr, K., Rémy Meier, J Häussler, et al.. (1996). Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.. Gut. 39(2). 319–324. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact